MaxCyte, Inc. (MXCT)
MXCT moved a median of -0.12% 30 minutes after news, and 0.00% by the close. How MXCT actually reacts to news — the realized, point-in-time move the market made, measured across 381 labeled events over the last three years with zero look-ahead.
MXCT’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 38% | 375 |
| 30-min | -0.12% | 41% | 380 |
| 60-min | -0.05% | 45% | 380 |
| to close | 0.00% | 48% | 377 |
| Middle 50% of MXCT reactions | -1.14% to +0.67% |
|---|---|
| Median reaction (30-min) | -0.12% |
| Measured reactions | 381 |
Half of all MaxCyte, Inc. news events land between -1.14% and +0.67% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
How MXCT reacts, by analyst action.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades | 10 | 0.00% | 60% | 0.00% |
| Analyst downgrades | 14 | -2.72% | 14% | -2.94% |
| Rating reiterations | 20 | -0.06% | 45% | +0.51% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The same measurement runs across every name in the dataset. 2 further classes were observed with fewer than 10 measured events and are not published. See how MXCT ranks against every other measured name →
That’s how MXCT usually reacts — get an email when it moves on news →Email me when MXCT moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to MXCT's baseline. Nothing else.
Recent MXCT events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form 8-K MAXCYTE, INC. For: Oct 14 | SEC filing · Form 8-K | SEC EDGAR | +4.92% | +2.46% | |
| MaxCyte Reports Preliminary Third Quarter 2026 Revenue and Raises Full Year 2026 Revenue Guidance | Press release | GlobeNewswire | +4.92% | +2.46% | |
| MaxCyte Appoints Sidharth Kapileshwar as Chief Corporate Development Officer | Press release | GlobeNewswire | +0.00% | -4.03% | |
| MaxCyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Press release | GlobeNewswire | -1.30% | +2.17% | |
| MaxCyte launches CHANGE-seq-BE™ and ONE-seq-BE™ to strengthen off-target assessment for genome editing therapies | Press release | GlobeNewswire | +0.78% | +7.75% | |
| Form 10-Q MAXCYTE, INC. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -1.73% | -5.04% | |
| Form 8-K MAXCYTE, INC. For: Aug 12 | SEC filing · Form 8-K | SEC EDGAR | +15.38% | +18.80% | |
| MaxCyte Reports Second Quarter 2026 Financial Results | Press release | GlobeNewswire | +15.38% | +18.80% | |
| MaxCyte® Announces Multi-Platform Technology License Partnership with Genentech® to Advance Cell Therapy Development | Press release | GlobeNewswire | +2.53% | +3.36% | |
| MaxCyte to Report Second Quarter 2026 Financial Results on August 12, 2026 | Press release | GlobeNewswire | +0.35% | -4.93% | |
| Form 8-K MAXCYTE, INC. For: Jun 17 | SEC filing · Form 8-K | SEC EDGAR | +1.32% | +6.14% | |
| Form 8-K MAXCYTE, INC. For: Jun 10 | SEC filing · Form 8-K | SEC EDGAR | -0.09% | -0.88% | |
| Form 10-Q MAXCYTE, INC. For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | -1.44% | +4.81% | |
| Form 8-K MAXCYTE, INC. For: May 12 | SEC filing · Form 8-K | SEC EDGAR | +5.31% | +8.50% | |
| MaxCyte Reports First Quarter 2026 Financial Results and Reiterates Full Year 2026 Guidance | Press release | GlobeNewswire | +5.31% | +8.50% | |
| Form ARS MAXCYTE, INC. For: Dec 31 | SEC filing · Form ARS | SEC EDGAR | -0.24% | +9.73% | |
| Form DEF 14A MAXCYTE, INC. For: Jun 17 | SEC filing · Form DEF | SEC EDGAR | -0.24% | +9.73% | |
| Form DEFA14A MAXCYTE, INC. | SEC filing · Form DEFA14A | SEC EDGAR | -0.24% | +9.73% | |
| MaxCyte to Report First Quarter 2026 Financial Results on May 12, 2026 | Press release | GlobeNewswire | -0.24% | +9.73% | |
| Form S-8 MAXCYTE, INC. | SEC filing · Form S-8 | SEC EDGAR | +0.87% | -2.67% | |
| MaxCyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Press release | GlobeNewswire | -3.55% | +1.93% | |
| Form 8-K MAXCYTE, INC. For: Mar 23 | SEC filing · Form 8-K | SEC EDGAR | +0.82% | +2.56% | |
| Form 10-K MAXCYTE, INC. For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +2.66% | +7.79% | |
| Form 8-K MAXCYTE, INC. For: Mar 24 | SEC filing · Form 8-K | SEC EDGAR | +1.05% | -5.53% | |
| MaxCyte Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Guidance | Press release | GlobeNewswire | +1.05% | -5.53% | |
| MaxCyte Appoints Parmeet Ahuja as Chief Financial Officer | Press release | GlobeNewswire | +0.00% | -1.70% | |
| Form 8-K MAXCYTE, INC. For: Mar 16 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -1.70% | |
| MaxCyte unveils ExPERT DTx™, a 96-well electroporation platform to accelerate discovery | Press release | GlobeNewswire | -1.67% | +3.25% | |
| MaxCyte to Report Fourth Quarter and Full Year 2025 Financial Results on March 24, 2026 | Press release | GlobeNewswire | -1.67% | +3.25% | |
| Form 8-K MAXCYTE, INC. For: Jan 12 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -4.38% | |
| MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results | Press release | GlobeNewswire | -3.71% | -4.89% | |
| Cellares Appoints Former MaxCyte Commercial Chief Ali Soleymannezhad as Chief Commercial Officer to Lead Global IDMO Expansion, Catalyze Next Wave of Partnerships, Prepare for IPO | Press release | Business Wire | -1.73% | -5.78% | |
| Form 8-K MAXCYTE, INC. For: Nov 12 | SEC filing · Form 8-K | SEC EDGAR | +3.95% | — | |
| MaxCyte Announces Planned CFO Transition in 2026 | Press release | GlobeNewswire | +3.95% | — | |
| MaxCyte Reports Third Quarter 2025 Financial Results and Reiterates Full Year 2025 Revenue Guidance | Press release | GlobeNewswire | +3.95% | — | |
| Form 8-K MAXCYTE, INC. For: Nov 05 | SEC filing · Form 8-K | SEC EDGAR | -3.66% | -10.37% | |
| MaxCyte Reports Preliminary Third Quarter 2025 Financial Results and Reiterates Full Year 2025 Revenue Guidance | Press release | GlobeNewswire | -0.34% | +12.84% | |
| MaxCyte to Report Third Quarter 2025 Financial Results on November 5, 2025 | Press release | GlobeNewswire | +0.95% | +8.28% | |
| MaxCyte Announces Strategic Platform License Agreement with Moonlight Bio to Advance T Cell Therapies for Solid Tumors | Press release | GlobeNewswire | -0.28% | -6.25% | |
| Form 8-K MAXCYTE, INC. For: Sep 22 | SEC filing · Form 8-K | SEC EDGAR | +2.75% | +8.23% | |
| MaxCyte Announces Operational Restructuring to Reduce Costs and Accelerate Path to Profitability | Press release | GlobeNewswire | +2.75% | +8.23% | |
| Form S-8 MAXCYTE, INC. | SEC filing · Form S-8 | SEC EDGAR | +0.36% | +0.72% | |
| Form 8-K MAXCYTE, INC. For: Aug 11 | SEC filing · Form 8-K | SEC EDGAR | -2.19% | — | |
| Form 10-Q MAXCYTE, INC. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -10.05% | -15.88% | |
| Form 8-K MAXCYTE, INC. For: Aug 06 | SEC filing · Form 8-K | SEC EDGAR | -10.05% | -15.88% | |
| MaxCyte Reports Second Quarter 2025 Financial Results and Updates Full Year 2025 Guidance | Press release | GlobeNewswire | -10.05% | -15.88% | |
| MaxCyte Signs Platform License Agreement with Adicet Bio | Press release | GlobeNewswire | -2.36% | +0.00% | |
| MaxCyte Announces Strategic Platform Licensing Agreement with Anocca AB to Advance TCR-T Cell Therapy Pipeline | Press release | GlobeNewswire | -2.40% | -0.96% | |
| MaxCyte to Report Second Quarter 2025 Financial Results on August 6, 2025 | Press release | GlobeNewswire | +1.33% | +0.00% | |
| Form 8-K MAXCYTE, INC. For: Jun 25 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +3.14% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the MXCT section they belong to.
Where else MXCT is measured.
MXCT earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is MaxCyte, Inc.'s median reaction calculated?
Every labeled MXCT news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 381 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 41% of MXCT's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does MXCT's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.